|
Market Cap (16-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
A news article has been posted about Telix Pharmaceuticals on the AFR. The article was published around , on 5 January 2024 at 11:08am.
Australian shares shrug off Wall Street losses to push higher. Telix Pharmaceuticals mulls Nasdaq listing. BlueBet jumps on merger talks. Follow updates here.
Read ArticleTLX was $11.22 at the close of trade on 30 June 2023
| Recent Articles about ASX:TLX | |
|---|---|
| 10-May | Anne Whitaker Board Resignation
company-announcements.afr.com |
| 7-May | 6 May 2025 Notice under section 708A(5)(e) of the Corporations Act ...
company-announcements.afr.com |
| 6-May | Appendix 2A - Application for quotation of securities
company-announcements.afr.com |
| 30-Apr | Telix Notice of Annual General Meeting
company-announcements.afr.com |
| 28-Apr | Telix Provides Regulatory Update on TLX101-CDx
company-announcements.afr.com |
| 24-Apr | Pending Release of Shares from Voluntary Escrow
company-announcements.afr.com |
| 23-Apr | Telix Reports US$186M Q1 Revenue, Up 62% YOY
company-announcements.afr.com |
| 20-Apr | Search Results | Herald Sun
heraldsun.com.au |
| 17-Apr | Search Results | Herald Sun
heraldsun.com.au |
| 17-Apr | IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma ...
company-announcements.afr.com |
| Tracked |
Find all articles about Telix Pharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.
Telix Pharmaceuticals 